Pulse Biosciences (PLSE) Operating Leases (2020 - 2025)
Historic Operating Leases for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $7.9 million.
- Pulse Biosciences' Operating Leases fell 570.1% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 570.1%. This contributed to the annual value of $8.9 million for FY2024, which is 269.03% down from last year.
- Pulse Biosciences' Operating Leases amounted to $7.9 million in Q3 2025, which was down 570.1% from $8.2 million recorded in Q2 2025.
- Pulse Biosciences' Operating Leases' 5-year high stood at $10.6 million during Q1 2021, with a 5-year trough of $7.9 million in Q3 2025.
- Its 5-year average for Operating Leases is $9.3 million, with a median of $9.4 million in 2022.
- Within the past 5 years, the most significant YoY rise in Pulse Biosciences' Operating Leases was 5892.38% (2021), while the steepest drop was 2522.66% (2021).
- Pulse Biosciences' Operating Leases (Quarter) stood at $8.1 million in 2021, then rose by 24.17% to $10.0 million in 2022, then decreased by 8.92% to $9.1 million in 2023, then dropped by 2.69% to $8.9 million in 2024, then fell by 11.33% to $7.9 million in 2025.
- Its Operating Leases was $7.9 million in Q3 2025, compared to $8.2 million in Q2 2025 and $8.6 million in Q1 2025.